{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T20:36:19Z","timestamp":1719261379071},"reference-count":36,"publisher":"Impact Journals, LLC","issue":"38","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,5,18]]},"DOI":"10.18632\/oncotarget.24837","type":"journal-article","created":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T09:24:15Z","timestamp":1526635455000},"page":"24927-24935","source":"Crossref","is-referenced-by-count":8,"title":["HIV-1 integrase strand-transfer inhibitor resistance in southern Taiwan"],"prefix":"10.18632","volume":"9","author":[{"given":"Hung-Chin","family":"Tsai","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"},{"name":"Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan"},{"name":"Department of Parasitology, Kaohsiung Medical University, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Tzu","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Sheng","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"},{"name":"Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Ting","family":"Tseng","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Len","family":"Sy","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jui-Kuang","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan Shin-Jung","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"},{"name":"Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao-Shen","family":"Chen","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan"},{"name":"Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2018,5,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1473-3099(11)70032-9","article-title":"Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study","volume":"11","author":"Antinori","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"2","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1093\/jac\/dkr601","article-title":"Trends of transmitted drug resistance of HIV-1 and its impact on treatment response to first-line anti-retroviral therapy in Taiwan","volume":"67","author":"Chang","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jac\/dkv284","article-title":"Transmitted drug resistance of HIV-1 strains among individuals attending voluntary counselling and testing in Taiwan","volume":"71","author":"Hung","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jmii.2014.08.002","article-title":"Prevalence and associated factors for HIV-1 transmitted drug resistance in voluntary clients for counseling and testing in Southern Taiwan","volume":"49","author":"Chen","year":"2016","journal-title":"J Microbiol Immunol Infect"},{"key":"5","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1093\/jac\/dkv202","article-title":"Primary resistance to integrase strand-transfer inhibitors in Europe","volume":"70","author":"Kostrikis","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s15010-016-0936-5","article-title":"Prevalence of integrase inhibitor resistance mutations in Austrian patients recently diagnosed with HIV from 2008 to 2013","volume":"45","author":"Puchhammer-Stoeckl","year":"2017","journal-title":"Infection"},{"key":"7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/infdis\/jiv012","article-title":"Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012","volume":"212","author":"Vernazza","year":"2015","journal-title":"J Infect Dis"},{"key":"8","doi-asserted-by":"crossref","first-page":"35779","DOI":"10.1038\/srep35779","article-title":"Prevalence of Integrase Strand Transfer Inhibitors (INSTI) Resistance Mutations in Taiwan","volume":"6","author":"Chang","year":"2016","journal-title":"Sci Rep"},{"key":"9","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1093\/jac\/dkv243","article-title":"Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades","volume":"70","author":"Geretti","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3851\/IMP2780","article-title":"Lack of resistance to integrase inhibitors among antiretroviral-naive subjects with primary HIV-1 infection, 2007-2013","volume":"20","author":"Collier","year":"2015","journal-title":"Antivir Ther"},{"key":"11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.7326\/0003-4819-125-4-199608150-00001","article-title":"Clinical and epidemiologic features of primary HIV infection","volume":"125","author":"Corey","year":"1996","journal-title":"Ann Intern Med"},{"key":"12","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1469-0691.2010.03375.x","article-title":"Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption","volume":"17","author":"Clementi","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"13","doi-asserted-by":"crossref","first-page":"e007334","DOI":"10.1136\/bmjopen-2014-007334","article-title":"Chemokine co-receptor usage in HIV-1-infected treatment-na\u00efve voluntary counselling and testing clients in Southern Taiwan","volume":"5","author":"Chen","year":"2015","journal-title":"BMJ Open"},{"key":"14","first-page":"132","article-title":"Update of the Drug Resistance Mutations in HIV-1","volume":"24","author":"Richman","year":"2017","journal-title":"Top Antivir Med"},{"key":"15","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1093\/jac\/dkq326","article-title":"Specific HIV-1 integrase polymorphisms change their prevalence in untreated versus antiretroviral-treated HIV-1-infected patients, all naive to integrase inhibitors","volume":"65","author":"Calvez","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"16","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1128\/AAC.00397-09","article-title":"Natural polymorphisms of human immunodeficiency virus type 1 integrase and inherent susceptibilities to a panel of integrase inhibitors","volume":"53","author":"Markowitz","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/JVI.69.1.376-386.1995","article-title":"Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells","volume":"69","author":"Muesing","year":"1995","journal-title":"J Virol"},{"key":"18","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1128\/AAC.01218-07","article-title":"The naphthyridinone GSK364735 is a novel, potent human immunodeficiency virus type 1 integrase inhibitor and antiretroviral","volume":"52","author":"Allen","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"19","doi-asserted-by":"crossref","first-page":"11233","DOI":"10.1073\/pnas.0402357101","article-title":"A naphthyridine carboxamide provides evidence for discordant resistance between mechanistically identical inhibitors of HIV-1 integrase","volume":"101","author":"Felock","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"20","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12985-017-0887-1","article-title":"Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors","volume":"14","author":"K\u00fccherer","year":"2017","journal-title":"Virol J"},{"key":"21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1742-4690-9-81","article-title":"Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients","volume":"9","author":"Grossman","year":"2012","journal-title":"Retrovirology"},{"key":"22","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2217\/fmb.13.10","article-title":"HIV-1 drug resistance: where do polymorphisms fit in?","volume":"8","author":"Vandamme","year":"2013","journal-title":"Future Microbiol"},{"key":"23","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/QAI.0b013e31802ea4c6","article-title":"Impact of syphilis infection on HIV viral load and CD4 cell counts in HIV-infected patients","volume":"44","author":"Santos","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"24","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1093\/jac\/dku535","article-title":"Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients","volume":"70","author":"Mont\u00e8s","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"25","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/infdis\/jir025","article-title":"HIV-1 integrase inhibitor resistance and its clinical implications","volume":"203","author":"Shafer","year":"2011","journal-title":"J Infect Dis"},{"key":"26","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/cid\/cis254","article-title":"Patterns of HIV-1 drug resistance after first-line anti-retroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies","volume":"54","author":"Rinke de Wit","year":"2012","journal-title":"Clin Infect Dis"},{"key":"27","doi-asserted-by":"crossref","first-page":"S334","DOI":"10.1093\/cid\/cir1017","article-title":"Surveillance of transmitted HIV-1 drug resistance in Gauteng and KwaZulu-Natal Provinces, South Africa, 2005-2009","volume":"54","author":"Morris","year":"2012","journal-title":"Clin Infect Dis"},{"key":"28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S1473-3099(11)70216-X","article-title":"Time to get serious about HIV anti-retroviral resistance","volume":"11","author":"Montaner","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"29","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/QAI.0b013e3181c7d363","article-title":"The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China","volume":"53","author":"Shao","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.antiviral.2010.07.008","article-title":"Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan","volume":"88","author":"Kato","year":"2010","journal-title":"Antiviral Res"},{"key":"31","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1089\/aid.2013.0184","article-title":"HIV anti-retroviral resistance mutations among anti-retroviral treatment-naive and -experienced patients in South Korea","volume":"29","author":"Song","year":"2013","journal-title":"AIDS Res Hum Retroviruses"},{"key":"32","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1758-2652-15-12","article-title":"Emergence of HIV-1 drug resistance mutations among anti-retroviral-na\u00efve HIV-1-infected patients after rapid scaling up of anti-retroviral therapy in Thailand","volume":"15","author":"Chantratita","year":"2012","journal-title":"J Int AIDS Soc"},{"key":"33","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1086\/428096","article-title":"Epidemiology and predictive factors for chemokine receptor use in HIV-1 infection","volume":"191","author":"Gazzard","year":"2005","journal-title":"J Infect Dis"},{"key":"34","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/jac\/dkm012","article-title":"Prevalence of X4 tropic viruses in patients recently infected with HIV-1 and lack of association with transmission of drug resistance","volume":"59","author":"Soriano","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"35","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1128\/JCM.00704-10","article-title":"Low frequency of CXCR4-using viruses in patients at the time of primary non-subtype-B HIV-1 infection","volume":"48","author":"Izopet","year":"2010","journal-title":"J Clin Microbiol"},{"key":"36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/jac\/dkt426","article-title":"Longitudinal analysis of HIV-1 coreceptor tropism by single and triplicate HIV-1 RNA and DNA sequencing in patients undergoing successful first-line antiretroviral therapy","volume":"69","author":"Moroni","year":"2014","journal-title":"J Antimicrob Chemother"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T22:03:20Z","timestamp":1661292200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.24837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,18]]},"references-count":36,"journal-issue":{"issue":"38","published-print":{"date-parts":[[2018,5,18]]}},"alternative-id":["24837","29861843"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.24837","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,18]]}}}